Proof-of-concept Study Evaluating Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Conditions: Hidradenitis Interventions: Drug: Amlitelimab; Drug: Placebo Sponsors: Sanofi Not yet recruiting

Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials